Tsuda M, Muraoka Y, Nagai M, Aoyagi T, Takeuchi T
Institute of Microbial Chemistry, Tokyo, Japan.
J Antibiot (Tokyo). 1996 Oct;49(10):1022-30. doi: 10.7164/antibiotics.49.1022.
Non-peptidyl postatin analogues, (S)-N-substituted-2-[2-(1-acylpyrrolidinyl)]-2-oxoacetamides were synthesized and examined for their inhibitory activity against prolyl endopeptidase and cathepsin B in vitro. Many compounds showed stronger activity than natural poststatin, a pentapeptide. Among them, (S)-N-cyclohexyl-2-oxo-2-[2-(1-(3-phenoxybenzoyl)pyrrolidinyl)]ace tamide (22) and (S)-N-cyclohexyl-2-[2-(1-(2-naphthoyl)pyrrolidinyl)]-2-oxoacetamide++ + (19) indicated IC50 value of 5.8 and 8.2 ng/ml for prolyl endopeptidase inhibition respectively. None of these compounds possess significant inhibitory activities against cathepsin B, a cysteine protease. These results indicate that these compounds are more selective inhibitors against prolyl endopeptidase than is natural poststatin.
合成了非肽基波他汀类似物,即(S)-N-取代-2-[2-(1-酰基吡咯烷基)]-2-氧代乙酰胺,并在体外检测了它们对脯氨酰内肽酶和组织蛋白酶B的抑制活性。许多化合物表现出比天然五肽波他汀更强的活性。其中,(S)-N-环己基-2-氧代-2-[2-(1-(3-苯氧基苯甲酰基)吡咯烷基)]乙酰胺(22)和(S)-N-环己基-2-[2-(1-(2-萘甲酰基)吡咯烷基)]-2-氧代乙酰胺(19)对脯氨酰内肽酶抑制的IC50值分别为5.8和8.2 ng/ml。这些化合物对组织蛋白酶B(一种半胱氨酸蛋白酶)均无显著抑制活性。这些结果表明,与天然波他汀相比,这些化合物是对脯氨酰内肽酶更具选择性的抑制剂。